𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A novel GJB1 mutation in an Italian patient with Charcot–Marie–Tooth disease and pyramidal signs

✍ Scribed by Marco Luigetti; Gian Maria Fabrizi; Federico Ranieri; Federica Taioli; Amelia Conte; Alessandra Del Grande; Mario Sabatelli

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
101 KB
Volume
44
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel mutations in the Charcot-Marie-Too
Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1
✍ Kathrin Huehne; Vladimir Benes; Christian Thiel; Cornelia Kraus; Wolfram Kress; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 28 KB

Charcot-Marie-Tooth disease (CMT) is a clinically and genetically heterogeneous disorder of the peripheral nervous system. CMT type 1 is most frequently caused by a 1.4 Mb tandem duplication in chromosome 17p11.2 comprising the peripheral myelin protein 22 (PMP22) gene. Furthermore sequence variatio

Molecular analysis in Japanese patients
Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations
✍ Chikahiko Numakura; Changqing Lin; Tohru Ikegami; Per Guldberg; Kiyoshi Hayasaka 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Charcot-Marie-Tooth disease (CMT) is a heterogeneous disorder and is traditionally classified into two major types, CMT type 1 (CMT1) and CMT type 2 (CMT2). Most CMT1 patients are associated with the duplication of 17p11.2-p12 (CMT1A duplication) and small numbers of patients have mutations of the p

X-linked Charcot–Marie–Tooth disease: Ph
X-linked Charcot–Marie–Tooth disease: Phenotypic expression of a novel mutation Ile127Ser in the GJB1 (connexin 32) gene
✍ Petr Vondracek; Pavel Seeman; Marketa Hermanova; Lenka Fajkusova 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

## Abstract We report a family with X‐linked dominant Charcot–Marie–Tooth disease (CMTX1). Three affected family members are described, who underwent detailed clinical, electrophysiological, molecular genetic, and histopathological studies. A novel isoleucine at position 127 with serine (Ile127Ser)